Liquid biopsy

Using a simple blood test to identify the tissue source and genes of dead cells may be a step forward for noninvasive biopsies

With better assays comes the need for better controls – are liquid biopsies and cell line-derived controls a match made in heaven?

Results presented at IASLC 2020 highlight the promising role of liquid biopsy in non-small cell lung carcinoma testing

Tapping into CSF and blood may overcome the challenges of diagnosing and monitoring brain tumors

What ctDNA and CTCs can tell us about the likelihood of breast cancer survival and recurrence

A new algorithm may help identify rare circulating tumor cells to improve liquid biopsy

Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?

A new, biomarker-based test may allow sepsis diagnosis and intervention before patients become symptomatic

To improve cancer screening compliance, patients may benefit from sensitive, specific, noninvasive blood tests

A new combination of urine biomarkers could help avoid the 60 percent of unnecessary biopsies for prostate cancer